Synthetic vascular hemodialysis access versus native arteriovenous fistula: A cost-utility analysis

Annals of Surgery

Volumn 255, Issue 1, 2012, Pages 181-186

  Rosas, Sylvia E ^a,b   Feldman, Harold I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CATHETER COMPLICATION; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; MALE; NATIVE ARTERIOVENOUS FISTULA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SYNTHETIC VASCULAR HEMODIALYSIS ACCESS; TREATMENT OUTCOME; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; GRAFT OCCLUSION, VASCULAR; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MARKOV CHAINS; MEDICAID; MEDICARE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; QUALITY-ADJUSTED LIFE YEARS; RENAL DIALYSIS; REOPERATION; SURVIVAL RATE; UNITED STATES;

EID: 84155172274     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822f4e9b     Document Type: Article

References (40)

1. Feldman H, Held P, Hutchinson J, et al. Hemodialysis vascular accessmorbidity in the United States. Kidney Int. 1993;43:1091-1096. (Pubitemid 23137095)
2. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis. 2001;37:S137-S181.
3. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002;62:1109-1124.
4. Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60:1443-1451. (Pubitemid 32960038)
5. Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449-1455. (Pubitemid 41716530)
6. Feldman HI, Joffe M, Rosas SE, et al. Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis. 2003;42:1000-1012. (Pubitemid 37322917)
7. Field M, MacNamara K, Bailey G, et al. Primary patency rates of AV fistulas and the effect of patient variables. J Vasc Access. 2008;9:45-50. (Pubitemid 351618715)
8. Palder SB, Kirkman RL, Whittemore AD, et al. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg. 1985;202:235-239. (Pubitemid 15041725)
9. Winsett OE, Wolma FJ. Complications of vascular access for hemodialysis. Sout Med J. 1985;78:513-517. (Pubitemid 15036606)
10. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164-2171. (Pubitemid 351679707)
11. Huijbregts HJ, Bots ML, Wittens CH, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008;3:714-719.
12. Nguyen TH, Bui TD, Gordon IL, et al. Functional patency of autogenous AV fistulas for hemodialysis. J Vasc Access. 2007;8:275-280. (Pubitemid 351266042)
13. United StatesRenal Data System. Annual Data Report. BethesdaMD: National Institutes of Health; 1997.
14. Avorn J, Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55:711-716. (Pubitemid 34831061)
15. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular accessmorbidity [editorial]. J Am Soc Nephrol. 1996;7:523-535.
16. Rosas SE, Joffe M, Burns JE, et al. Determinants of successful synthetic hemodialysis vascular access graft placement. J Vasc Surg. 2003;37:1036-1042. (Pubitemid 36538928)
17. Hirth RA, Turenne MN, Woods JD, et al. Predictors of type of vascular access in hemodialysis patients [see comments]. Jama. 1996;276:1303-1308. (Pubitemid 26346929)
18. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997;30:S150-S191.
19. Centers for Medicare & Medicaid Services. CMS launches breakthrough initiative for major improvement in care for kidney patients: safe vascular access through collaborative fistula first initiative [press release].Centers forMedicare & Medicaid Services; 17, 2005.
20. Tonnessen BH, Money SR. Embracing the fistula first national vascular access improvement initiative. J Vasc Surg. 2005;42:585-586. (Pubitemid 41323859)
21. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Deci Making. 1983;3:419-458. (Pubitemid 14196965)
22. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Dec Making. 1993;13:322-338. (Pubitemid 24013155)
23. United States Renal Data System. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health; 2007.
24. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System. Am J Kidney Dis. 1997;30:S160-S177.
25. Nissenson AR, Dylan ML, Griffiths RI, et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis. 2005;46:301-308. (Pubitemid 41040359)
26. Jungers P, Zingraff J, Page B, et al. Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int Suppl. 1993;41:S170-S173.
27. Sands JJ. Increasing AV fistulas: revisiting a time-tested solution. Semin Dial. 2000;13:351-353.
28. Reddan D, Klassen P, Frankenfield DL, et al. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol. 2002;13:2117-2124. (Pubitemid 34790789)
29. Saran R, Elder SJ, Goodkin DA, et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg. 2008;247:885-891. (Pubitemid 351591526)
30. Chertow GM. Grafts vs fistulas for hemodialysis patients: equal access for all? [editorial; comment]. Jama. 1996;276:1343-1344.
31. Tordoir JH, Herman JM, Kwan TS, et al. Long-term follow-up of the polytetrafluoroethylene (PTFE) prosthesis as an arteriovenous fistula for haemodialysis. Eur J Vascul Surg. 1987;2:3-7. (Pubitemid 19217697)
32. Rizzuti RP, Hale JC, Burkart TE. Extended patency of expanded polytetrafluoroethylene grafts for vascular access using optimal configuration and revisions. Surg, Gynecol Obstet. 1988;166:23-27. (Pubitemid 18087907)
33. Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360:2191-2201.
34. Beathard GA, Settle SM, Shields MW. Salvage of the nonfunctioning arteriovenous fistula. Am J Kidney Dis. 1999;33:910-916. (Pubitemid 29214689)
35. SilvaMB Jr., Hobson RWII, Pappas PJ, et al. Vein transposition in the forearm for autogenous hemodialysis access [comment]. J Vascul Surg. 1997;26:981-986. Discussion 7-8.
36. Konner K, Hulbert-Shearon TE, Roys EC, et al. Tailoring the initial vascular access for dialysis patients. Kidney Int. 2002;62:329-338. (Pubitemid 34754079)
37. Wasse H, Speckman RA, McClellan WM. Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial. 2008;21:483-489.
38. Sands J, Miranda CL. Increasing numbers of AV fistulas for hemodialysis access. Clin Nephrol. 1997;48:114-117. (Pubitemid 27371041)
39. Gibson KD, Caps MT, Kohler TR, et al. Assessment of a policy to reduce placement of prosthetic hemodialysis access. Kidney Int. 2001;59:2335-2345. (Pubitemid 32467628)
40. Schon D, Blume SW, Niebauer K, et al. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol. 2007;2:268-276.